UAE-based biotechnology company, Hayat Biotech on Tuesday stated its interest to cooperate and invest in the digitization of Pakistan’s health sector.
The interest was shown by a designation of Hayat Biotech and Sinopharm, which run by Saboor Karamat, General Counsel of the UAE’s Sheikh Ahmed Dalmook Al-Maktoum, who named on Prime Minister Shehbaz Sharif here.
Minister for National Health Services Abdul Qadir Patel and pertinent senior officials were also present in the meeting.
He acclaimed the deep interest of Sheikh Ahmed Dalmook Al-Maktoum for cooperation and investment in Pakistan’s health sector.
Throughout the meeting, it was told that due to lack of plasma fractionation facilities in Pakistan, the annual 3 million liters of blood collection in the country was not fully employed. After the formation of plasma fractionation facility in Pakistan, thousands of lives will be saved through the utilization of all contents to be separated from the donated blood.
The prime minister directed all the related institutions to fully facilitate the companies for the proposed project.
Previously, it emerged that the United Arab Emirates (UAE) is planning to invest one billion dollars in Pakistan’s economic and investment sectors, quoting an official source in Abu Dhabi the state news agency has reported.
Read Also: UAE planning to invest one billion dollars in Pakistan
The move purposes at exploring new investment opportunities, growing bilateral economic relations and to enhance mutual cooperation in projects covering numerous sectors of the economy.